[Problems of anticoagulant and thrombolytic therapy in sinus and cerebral vein thromboses].
D000925:Anticoagulants / Q000627:therapeutic use*; D001921:Brain / Q000098:blood supply; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003374:Coumarins / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D012851:Sinus Thrombosis, Intracranial / Q000188:drug therapy*; D013300:Streptokinase / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000188:drug therapy*; D014680:Veins
D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase
Problematik der Antikoagulantien- und Thrombolysetherapie bei Sinus- und Hirnvenenthrombosen.